Oramed reports 1Q loss

JERUSALEM (AP) _ Oramed Pharmaceuticals Inc. (ORMP) on Thursday reported a loss of $2.5 million in its fiscal first quarter.

The Jerusalem-based company said it had a loss of 18 cents per share.

The drug maker posted revenue of $611,000 in the period.

Oramed shares have decreased 2 percent since the beginning of the year. The stock has risen 35 percent in the last 12 months.

This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on ORMP at https://www.zacks.com/ap/ORMP